TY  - GEN
AU  - Nabholtz,J M
AU  - Senn,H J
AU  - Bezwoda,W R
AU  - Melnychuk,D
AU  - Deschênes,L
AU  - Douma,J
AU  - Vandenberg,T A
AU  - Rapoport,B
AU  - Rosso,R
AU  - Trillet-Lenoir,V
AU  - Drbal,J
AU  - Molino,A
AU  - Nortier,J W
AU  - Richel,D J
AU  - Nagykalnai,T
AU  - Siedlecki,P
AU  - Wilking,N
AU  - Genot,J Y
AU  - Hupperets,P S
AU  - Pannuti,F
AU  - Skarlos,D
AU  - Tomiak,E M
AU  - Murawsky,M
AU  - Alakl,M
AU  - Aapro,M
TI  - Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group
SN  - 0732-183X
PY  - 1999///0527
KW  - Adult
KW  - Aged
KW  - Analysis of Variance
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease Progression
KW  - Docetaxel
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Health Status
KW  - Humans
KW  - Middle Aged
KW  - Mitomycins
KW  - Neutropenia
KW  - chemically induced
KW  - Paclitaxel
KW  - Patient Compliance
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Survival Analysis
KW  - Taxoids
KW  - Thrombocytopenia
KW  - Vinblastine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.1999.17.5.1413
ER  -